New treatment for lung and kidney cancer on PBS
From 1 August, more than 4500 Australians will benefit each year from the listing of a revolutionary new medicine for lung and renal cancer on the Pharmaceutical Benefits Scheme (PBS). Nivolumab (sold as Opdivo®) is used to treat both locally advanced and metastatic stages of non-small cell lung cancer (NSCLC) and Stage IV clear cell…